Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea · Delayed Price · Currency is KRW 16,330
-570 (-3.37%)
At close: Jun 5, 2026
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 111.76 billion as of June 5, 2026. Its market cap has increased by 28.79% in one year.
Market Cap
111.76B
Enterprise Value
17.45B
Revenue
56.49B
Ranking
n/a
PE Ratio
8.33
Stock Price
16,330.00
Market Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 111.76B, an increase of 700.12%. That is a compound annual growth rate of 9.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 111.76B | 24.56% |
| Dec 30, 2025 | 89.72B | -8.13% |
| Dec 30, 2024 | 97.66B | 27.18% |
| Dec 28, 2023 | 76.79B | -11.65% |
| Dec 29, 2022 | 86.92B | -34.80% |
| Dec 30, 2021 | 133.30B | -19.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABION | 158.85B |
| Prestige Biologics | 142.13B |
| ISU Abxis | 132.93B |
| CORESTEMCHEMON | 129.31B |
| NovMetaPharma | 100.16B |
| QuadMedicine | 94.38B |
| Choong Ang Vaccine Laboratory | 87.87B |
| BIO-FD&C | 84.44B |